1) anti-AChR antibodies IgG
IgG型乙酰胆碱受体抗体
2) AchRab
抗乙酰胆碱受体抗体
1.
The levels of IFN-γ and IL-4 in cultured supernatants of PHA group were assayed after 48h in culture,AchRab and PsmRab production in cultured super.
培养后收集上清检测抗乙酰胆碱受体抗体 (Ach Rab)和抗突触前膜受体抗体 (Psm Rab)。
2.
Results:Both in seropositive or seronegative groups, the level of AChRab,PsmRab,IFN-γ and IL-4 increased in cultured supernatants after activated with PWM or PHA, have a statistical meaning compared with the control group (P=0.
结果 :无论SPMG或SNMG ,外周血单个核细胞体外培养后上清液中γ干扰素 (IFN γ)、白细胞介素 4(IL 4)、抗乙酰胆碱受体抗体 (AChRab)和抗突触前膜受体抗体 (Prsmab)均比健康对照组非常显著增高 (P =0 0 0 0 )。
3.
Objective:To investigate the correlation between the serum level of interleukin-18(IL-18) in MG and the clinic score of MG,the serum level of AchRab and PsmRab in MG .
目的:探讨白介素18(IL-18)与重症肌无力(MG)临床评分、抗乙酰胆碱受体抗体(AchRab)和抗突触前膜受体抗体(PsmRab)的关系及其在MG发病机制中的作用。
3) AchRAb
乙酰胆碱受体抗体
1.
Injury of the septo-hippocampal cholinergic system by intracerabral-injectionof AchRab IgG to rats;
脑内注射乙酰胆碱受体抗体IgG对大鼠隔-海马胆碱能系统的损害
2.
Effects of intraventricular injection of AchRab on the neuronal apoptosis and the expression of nitric oxide synthase in rat brains;
脑室内注射乙酰胆碱受体抗体IgG对大鼠神经元凋亡及一氧化氮合酶表达的影响
3.
Objective: To investigate the role of soluble CD40 ligand(sCD40L) in the pathogenesis of myasthenia gravis (MG), the concentration of sCD40L and AchRab in MG patient s serum was tested.
目的:研究重症肌无力(MG)患者血清中可溶性CD40配体(sCD40L)及抗乙酰胆碱受体抗体(AchRab)的水平,探讨sCD40L在MG发病中的作用。
4) acetylcholine receptor antibody
乙酰胆碱受体抗体
1.
Effect of glucocorticosteroid on interleukin-6 and acetylcholine receptor antibody of myasthenia gravis patients;
糖皮质激素对重症肌无力患者白细胞介素-6和乙酰胆碱受体抗体的影响(英文)
2.
Methods Using immunoprecipitation method,we measured the level of the serum acetylcholine receptor antibody(AChRAb) in 198 cases of myasthenia gravis(MG).
方法采用放射免疫法检测198例重症肌无力(MG)患者血清中抗乙酰胆碱受体抗体(AChRAb)水平,筛选出SNMG血清样本再行MuSKAb水平检测。
3.
Objective To observe the mechanism of Huangqi compound by regulating the acetylcholine receptor antibody (AChRAb) level in blood of myasthenia gravis (MG) patients.
目的采用中药黄芪复方调节重症肌无力(myastheniagravis,MG)患者血清乙酰胆碱受体抗体(acetylcholinereceptorantibody,AChRAb)水平,以探讨其治疗MG的可能作用机制。
5) Acetylcholine receptor antibody (AChRAb)
乙酰胆碱受体抗体(AChRAb)
6) nAChRs
烟碱型乙酰胆碱受体
1.
CoMFA method is used to build the relationship between activity and struture of a novel analogues of nicotinic acetylcholine receptor(nAChRs) agonists.
采用比较分子力场分析方法 ,对一系列与烟碱型乙酰胆碱受体作用的吡啶基醚类配体进行构效关系分析 ,建立了这类化合物的 3维构效模型 。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条